Authors: Russo, D Pricolo, G Michieli, M Michelutti, A Raspadori, D Bertone, A Marin, L Pierri, I Bucalossi, A Zuffa, E De Vivo, A Mazza, P Gobbi, M Lauria, F Zaccaria, A Baccarani, M

Citation: D. Russo et al., Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia, LEUK LYMPH, 40(3-4), 2001, pp. 335-343

Authors: Mazza, P Palazzo, G Amurri, B Pricolo, G Prudenzano, A Stani, L

Citation: P. Mazza et al., Rituximab with peripheral blood stem cell transplantation in CD20 lymphoproliferative disorders, HAEMATOLOG, 86(10), 2001, pp. 1104-1105

Authors: Mazza, P Amurri, B Palazzo, G Prudenzano, A Pricolo, G Stani, L

Citation: P. Mazza et al., Fludarabine-containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: a single center experience, HAEMATOLOG, 85(2), 2000, pp. 222-224

Authors: Mazza, P Palazzo, G Amurri, B Cervellera, M Manna, N Fellini, G Casulli, F Ghiggini, M Peluso, A Pricolo, G Prudenzano, A Stani, L

Citation: P. Mazza et al., Analysis of feasibility of myeloablative therapy and autologous peripheralstem cell (PBSC) transplantation in the elderly: an interim report, BONE MAR TR, 23(12), 1999, pp. 1273-1278